工作经历：2016年07月获中国科学院大学遗传学理学博士学位，2020年07月于美国密歇根大学完成博士后研究。2020年12月入职北京大学第三医院工作至今。现任研究员、博士生导师，负责中心实验室-生物信息平台的研发工作。

科研工作：围绕肿瘤驱动机制和细胞发育机制开展了遗传变异的功能注释和表观遗传调控网络研究。主持国自然面上基金1项、北京市科技新星基金1项。以第一或通讯作者（含共同）发表论文18篇，谷歌学术总引用一千余次。

学术兼职：担任计算生物学与生物信息学专委会专家委员、中国抗癌协会肿瘤标志专委会专家委员；担任Lancet Respiratory Medicine、Nucleic Acids Research、Briefings in Bioinformatics、Clinical and Translational Medicine等学术杂志的审稿专家。

获奖情况：2022年获中国肿瘤标志物学术大会论文三等奖。

代表性论文：

1. Fan Jibiao^#; Shi Leisheng^#; Liu Qi^#; Zhu Zhipeng; Wang Fan; Song Runxian; Su Jimeng; Zhou Degui; Chen Xiao; Li Kailong; Xue Lixiang^*; Sun Lichao^*; Mao Fengbiao^*. Annotation and evaluation of base editing outcomes in multiple cell types using CRISPRbase, Nucleic Acids Research, 2023, 51(D1): D1249-D1256.

2. Zhao Xiaolu^#; Shi Leisheng^#; Ruan Shasha^#; Bi Wenjian; Chen Yifan; Chen Lin; Liu Yifan; Li Mingkun^*; Qiao Jie^*; Mao Fengbiao^*. CircleBase: an integrated resource and analysis platform for human eccDNAs, Nucleic Acids Research, 2022, 50(D1): D72-D82.

3. Shi Xiaohui^#; Teng Huajing; Shi Leisheng; Bi Wenjian; Wei Wenqing; Mao Fengbiao^*; Sun Zhongsheng^*. Comprehensive evaluation of computational methods for predicting cancer driver genes, Briefings in Bioinformatics, 2022, 23(2): 1-14.

4. Wang Tao^#; Ruan Shasha^#; Zhao Xiaolu; Shi Xiaohui; Teng Huajing; Zhong Jianing; You Mingcong; Xia Kun^*; Sun Zhongsheng^*; Mao Fengbiao^*. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers, Nucleic Acids Research, 2021, 49(D1): D1289-D1301.

5. Teng Huajing^#; Wei Wenqing^#; Li Qinglan; Xue Meiying; Shi Xiaohui; Li Xianfeng; Mao Fengbiao^*; Sun Zhongsheng^*. Prevalence and architecture of posttranscriptionally impaired synonymous mutations in 8320 genomes across 22 cancer types, Nucleic Acids Research, 2020, 48(3): 1192- 1205.